Radius Health Announces Second Quarter 2020 Operating Results
(WorldNews Japan)

Radius Health Announces Second Quarter 2020 Operating Results TYMLOS®U.S. net sales of $50million, with 22% year over year growth Completion of enrollment in ATOM Phase 3 expected this week Phase 3 Trials: wearABLe and EMERALD remain on track Conference call scheduled for 8:30 a.m. ET today WALTHAM, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (`Radius` or the `Company`) (Nasdaq: RDUS), today reported its financial and operating results for the second quarter ended June 30, 2020 and provided a business update. `Completing the elacestrant transaction was an important step forward for the company, centering our clinical and regulatory strategy while strengthening ourselves from...